KMD Bioscience

KMD Bioscience Co., Ltd. was established in Tianjin, China in 2014. The founder team has many years of experience in human drug research and development. KMD Bioscience takes research & development as the foundation of its value and focuses on providing high-quality products and drug-antibody discovery services for global scientists, research institutes, and pharmaceutical companies. As a high-tech enterprise in China, KMD Bioscience has successfully obtained the ISO9001:2015 quality management system certification and national patent pilot laboratory honor. At present, the company has more than 30 patents and 2 registered trademarks. KMD Bioscience provides more than 800+ technical service consulting, custom service design, and project delivery for research institutes, hospitals, pharmaceutical companies, and biological companies worldwide every year. At the beginning of its establishment, KMD Bioscience started from the phage display technology platform to provide high-quality antibody discovery services and gradually established stable cell line construction and screening, natural protein extraction and fermentation, and recombinant protein custom expression services, a multi-species antibody discovery platform. Based on the above-mentioned major R&D platforms, KMD Bioscience has successfully developed many related reagents such as recombinant proteins, antibodies, antibody-drug similars, industrial enzymes, and diagnostic raw materials for scientific research and new drug discovery.

Lab Information

KMD Bioscience

Research Area and Skills

Recognize this scientist’s Expertise for their contribution in your research

Biochemistry 1 Biological Engineering 1 Biomedical Science 0 Cell Biology 0 Drug Screening 0 Drug Discovery 0 Protein Engineering 0

More

  • Post
  • Publication
  • Plasmid
  • Following (1)
  • Follower (1)

Over the years, KMD Bioscience has provided customers with a wide range of customized phosphorylated monoclonal and polyclonal antibodies. Based on our advanced technologies and extensive experience, KMD Bioscience can provide antibody services for specific phosphorylation sites ...Learn More


In the realm of modern medicine, the advent of humanized antibody therapy stands as a pivotal milestone, reshaping the landscape of disease treatment and management. With its profound implications for precision medicine, humanized antibody therapy has emerged as a cornerstone in ...Learn More


KMD Bioscience is a professional provider of antibody and recombinant protein products and services, with years of pre-clinical research experience and production experience to provide upstream and downstream services for antigen and antibody production. Whether you have a clearly ...Learn More


Antibody humanization strategies are critical for developing therapeutic antibodies that are effective and minimally immunogenic in humans. These strategies aim to reduce the immune response against therapeutic antibodies derived from non-human species, typically mice. The three ...Learn More


Production of single B cell antibodies is a newly developed technology for rapid production of monoclonal antibodies in recent years. Based on flow cytometry sorting technology, single B cell monoclonal antibodies are prepared, utilizing the characteristic that each B cell ...Learn More



This guy hasn’t publications anything yet.


This guy hasn’t plasmids anything yet.

Hot plasmids

Cloud Scientists

About Us · User Accounts and Benefits · Privacy Policy · Management Center · FAQs
© 2024 MolecularCloud